IP Library › Granted Patent US 7,658,951
Granted Patent B2
US 7,658,951 · App. 10/700,032 · Granted Feb 9, 2010

Method of improving cardiac function of a diseased heart

Assignee: Henry Ford Health System
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,658,951
App. No.
10/700,032
Granted
Feb 9, 2010
Kind
B2
Abstract

A method of treating heart failure and improving cardiac function by administering stem cell products to a heart in need of treatment, whereby the stem cell products improve cardiac muscle function thereby treating heart failure and improving cardiac function. A method of enriching or regenerating damaged myocardium by administering stem cell products to damaged myocardium. Stem cell products for use in treating heart failure are also provided. A composition for enriching and regenerating damaged myocardium, the composition having stem cell products in a pharmaceutically acceptable carrier.

Claims (19)

1. A method of improving cardiac function of a diseased heart, comprising:

administering hypoxic bone marrow stem cell (BMSC) preconditioned media into damaged tissue of the heart,

wherein the hypoxic BMSC preconditioned media is not populated by the bone marrow stem cells that were incubated under hypoxic conditions to produce the hypoxic BMSC preconditioned media; and

wherein the hypoxic BMSC preconditioned media is therapeutically effective for improving cardiac function by enrichment of the damaged tissue and stimulation of cardiac cell repopulation in the damaged tissue.

2. The method according to claim 1 , wherein said administering step includes administering the hypoxic BMSC preconditioned media in a method selected from the group consisting essentially of intravenously, intracoronary, and directly to the heart at a specific location of an injury.

3. A method of improving cardiac function of a diseased heart, comprising:

preparing a composition consisting of hypoxic bone marrow stem cell (BMSC) preconditioned media that is not populated by the bone marrow stem cells that were incubated under hypoxic conditions to produce the hypoxic BMSC preconditioned media; and

administering the composition into damaged tissue in the diseased heart to improve cardiac function by enriching the damaged tissue and stimulating repopulation of cardiac cells in the damaged tissue.

4. The method of claim 3 , wherein the preparing step comprises:

incubating bone marrow stem cells (BMSC) in media under 95% nitrogen and 5% carbon dioxide to produce an incubation product; and

removing the BMSC from the incubation product to produce the hypoxic BMSC preconditioned media.

5. A method of improving cardiac function of a diseased heart, comprising:

incubating a composition comprising bone marrow stem cells (BMSC) in media under hypoxic conditions;

harvesting the BMSC from the composition to obtain hypoxic bone marrow stem cell (BMSC) preconditioned media; and

administering the hypoxic BMSC preconditioned media into damaged tissue in the diseased heart to improve cardiac function by enriching the damaged tissue and stimulating repopulation of cardiac cells in the damaged tissue.

6. The method of claim 5 , further comprising, prior to the incubating step:

isolating the BMSC from harvested marrow; and

growing the isolated BMSC without differentiation in the media.

7. The method of claim 5 , wherein the hypoxic conditions of the incubating step are 95% nitrogen and 5% carbon dioxide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2004
From: SABBAH, HANI; MALTSEV, VICTOR; SHAROV, VICTOR G.; ISHIGAI, YUKATA
To: HENRY FORD HEALTH SYSTEM
Reel/Frame 014738/0765 →
Continuity (3)
Continuation In Part PCTUS022959500 · Sep 18, 2002
Provisional Application 6032335100 · Sep 19, 2001
Related Publication 20040180043A1 · Sep 16, 2004